Focused ultrasound market seen reaching $7.13 billion by 2030

The focused ultrasound system market is projected to grow from $4.33 billion in 2025 to $7.13 billion by 2030, according to a new report from The Business Research Company. The forecast points to rising demand for non-invasive therapies, aging populations and broader clinical use across oncology and neurology.

Why it matters: - Focused ultrasound is expanding as a non-invasive treatment option that can target tissue without surgery. - The market outlook signals more spending on medical imaging, precision therapy and clinical equipment. - Demand is being pushed by chronic disease prevalence and a growing need for alternatives to invasive procedures.

What happened: - The Business Research Company released its Focused Ultrasound System Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035. - The report values the global focused ultrasound system market at $4.33 billion in 2025. - The market is projected to rise to $4.79 billion in 2026, implying 10.7% annual growth. - The report forecasts the market will reach $7.13 billion by 2030, at a 10.4% CAGR. - The report was published Aug. 7, 2026. - The company offers a free sample report. - The company also links to the full market report.

The details: - The report says historical growth has been driven by ultrasound imaging improvements, rising demand for minimally invasive therapies and early tumor ablation use. - Clinical validation and hospital equipment upgrades also supported recent expansion. - Focused ultrasound systems use concentrated high-frequency sound waves to create a therapeutic effect in a specific target inside the body or material. - The systems typically include a transducer array, imaging guidance and a control unit. - The technology is used for tumor ablation, kidney stone disintegration, drug delivery enhancement and temporary blood-brain barrier opening for targeted therapies. - The report identifies chronic disease prevalence as a major market catalyst. - Macmillan Cancer Support reported in August 2024 that more than 3 million people in the UK were living with cancer. - Macmillan Cancer Support expects that figure to reach 3.5 million in 2025, 4 million in 2030 and 5.3 million by 2040.

Between the lines: - The strongest near-term opportunity appears to be in non-invasive and image-guided procedures, where focused ultrasound can replace or reduce surgery. - Broader adoption in neurology and oncology suggests the market is moving beyond niche use cases. - The 10.4% CAGR forecast through 2030 points to sustained demand, but the pace will likely depend on regulatory approvals and clinical uptake.

What's next: - The report expects growth to continue as the global population ages and precision medicine investments rise. - More regulatory approvals could widen the number of approved uses. - The Asia-Pacific region is expected to post the fastest growth over the forecast period. - North America was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western and Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - Focused ultrasound is moving from an emerging therapy to a broader medical technology category, with growth tied to chronic disease treatment, non-invasive care and expanding specialty uses.